Shanghai, China

Yilong Teng

This inventor holds 1 USPTO granted patent. Top assignee: Rongcan (Shanghai) Biotech Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yilong Teng. Retrieved from https://idiyas.com/inventor/yilong-teng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yilong Teng: Innovator in Biomedicine

Introduction

Yilong Teng is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biomedicine, particularly through his innovative work on lipid compounds. His research focuses on developing new materials that can enhance biomedical applications.

Latest Patents

Yilong Teng holds a patent for a lipid compound containing a carbamate bond and its applications. This invention discloses a class of lipid compounds that exhibit excellent biocompatibility and safety. The lipid nanoparticulate carriers prepared from these compounds show unexpected improvements in transfection efficiency, making them suitable for biomedical industrialization. He has 1 patent to his name.

Career Highlights

Yilong Teng is currently associated with Rongcan (Shanghai) Biotech Co., Ltd. His work at this company emphasizes the development of innovative biotechnological solutions that can be applied in various medical fields. His research has the potential to impact the way biomedical products are developed and utilized.

Collaborations

Yilong Teng collaborates with notable colleagues, including XueQing Zhang and Bin Zhang. Their combined expertise contributes to the advancement of biomedicine and the successful implementation of innovative technologies.

Conclusion

Yilong Teng is a key figure in the field of biomedicine, with a focus on lipid compounds that enhance transfection efficiency. His contributions are paving the way for future advancements in biomedical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…